Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink
Most DM1 patients died of known disease complications. This highlights the need for integrated clinical approaches with more careful and frequent monitoring.
Authors
- Emily Pearce (ORCID: https://orcid.org/0000-0003-4222-9340)
- Ruth M. Pfeiffer (ORCID: https://orcid.org/0000-0001-7791-2698)
- Rotana Alsaggaf (ORCID: https://orcid.org/0000-0001-5043-8789)
- Hanns Lochmüller (ORCID: https://orcid.org/0000-0003-2324-8001)
- Shahinaz M. Gadalla (ORCID: https://orcid.org/0000-0002-3255-8143)
- Mark H. Greene (ORCID: https://orcid.org/0000-0003-1852-9239)
Institutions
- National Institutes of Health (US)
- University of Ottawa (CA)
- Children's Hospital of Eastern Ontario (CA)
- Ottawa Hospital (CA)
- National Cancer Institute (US)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1002/mus.28308
- Citations
- 5
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.34
Funders
- Canada Foundation for Innovation
- Muscular Dystrophy Canada
- Canada Research Chairs
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute
- Division of Cancer Epidemiology and Genetics, National Cancer Institute